Impax Laboratories Management Discusses Q4 2012 Results – Earnings Call … – Seeking Alpha

by admin on February 26, 2013

Impax Laboratories Management Discusses Q4 2012 Results – Earnings Call
Seeking Alpha
In analysis of the study data indicate that although the results show a modest improvement in addressing Restless Legs Syndrome, the result did not achieve the statistical criteria for its primary efficacy endpoint compared to the placebo and does not
Impax Laboratories Reports Fourth Quarter and Full Year 2012 ResultsFort Mills Times

all 4 news articles »

View full post on restless leg syndrome – Google News

Leave a Comment

Previous post:

Next post: